✦ LIBER ✦

Better salvage therapy for HIV-1 infection still needed

✍ Scribed by Julio Montaner; John Mellors

Book ID: 117312165
Publisher: The Lancet
Year: 1999
Tongue: English
Weight: 54 KB
Volume: 353
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(99)00094-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Salvage therapy for HIV-1 infection—the

Salvage therapy for HIV-1 infection—the challenge grows

✍ John Mellors; Julio Montaner 📂 Article 📅 2000 🏛 The Lancet 🌐 English ⚖ 59 KB

Immunomodulators as adjunctive therapy f

Immunomodulators as adjunctive therapy for HIV-1 infection

✍ Sarah L Pett; Sean Emery 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 118 KB

New model for HIV-1 infection may alter

New model for HIV-1 infection may alter therapy

✍ Marilynn Larkin 📂 Article 📅 1996 🏛 The Lancet 🌐 English ⚖ 20 KB

Gene therapy for HIV infection: what doe

Gene therapy for HIV infection: what does it need to make it work?

✍ Dorothee von Laer; Susanne Hasselmann; Klaus Hasselmann 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

## Abstract The efficacy of antiviral drug therapy for HIV infection is limited by toxicity and viral resistance. Thus, alternative therapies need to be explored. Several gene therapeutic strategies for HIV infection have been developed, but in clinical testing therapeutically effective levels of t

Salvage therapy for zidovudine-intoleran

Salvage therapy for zidovudine-intolerant HIV-infected patients with alternating and intermittent regimens of zidovudine and dideoxycytidine

✍ Samuel A. Bozzette; Douglas D. Richman 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 392 KB

Emergence of cytomegalovirus resistance

Emergence of cytomegalovirus resistance to foscarnet in a patient receiving foscarnet salvage therapy for multidrug-resistant HIV infection

✍ David Boutolleau; Ana Canestri; Sonia Burrel; Marc Wirden; Sophie Seang; Cyril C 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 206 KB